Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Jan
8
2016
January 8, 2016 -- Biologics and Biosimilars Bits and Bytes Michael Best & Friedrich LLP
Apr
26
2017
New Guidelines in Brazil Give More Power to ANVISA in Examination of Pharmaceutical Patent Applications Michael Best & Friedrich LLP
Nov
13
2010
USPTO Extends and Expands the Green Technology Pilot Program Michael Best & Friedrich LLP
Sep
10
2013
Understanding Biologics and Biosimilars in Brazil Michael Best & Friedrich LLP
May
29
2014
An Overview of Biosimilars in the Russian Federation Michael Best & Friedrich LLP
Jun
13
2014
Cloning: It’s not what you think – Changes to ANVISA’s (Brazil Health Service Agency) “Clone” Procedure Michael Best & Friedrich LLP
Jun
25
2014
Is an Abbreviated Pathway for Biosimilars Coming Soon to China? Michael Best & Friedrich LLP
Feb
6
2015
Is Compulsory Licensing of Generic Medicines Coming to the Russian Federation? Michael Best & Friedrich LLP
Sep
18
2015
Indian Patent Office Rejects Pfizer’s Patent for Tofacitinib – Again! Michael Best & Friedrich LLP
Aug
19
2016
Updates to the Brazilian Food and Drug Administration OTC Drug Guidelines Michael Best & Friedrich LLP
Aug
23
2017
Understanding Bolar and Bolar-Like Exceptions in the U.S. and Abroad – Part 2 – Canada Michael Best & Friedrich LLP
Aug
29
2010
States to Re-evaluate Feed-in Tariffs After Recent FERC Ruling Michael Best & Friedrich LLP
Nov
14
2010
EPA Issues Guidance on Permitting for GHG Emissions Michael Best & Friedrich LLP
Jan
18
2011
EPA Defers GHG Permitting Requirements for Biomass Industries Michael Best & Friedrich LLP
Feb
28
2013
High Impact Entrepreneurship in Wisconsin: The Smoke and the Fire Michael Best & Friedrich LLP
Apr
26
2013
Expanding Market for Technologies to Clean Wastewater from Hydraulic Fracturing Michael Best & Friedrich LLP
Feb
25
2014
Phosphorus Legislation Passes Both Wisconsin Houses Michael Best & Friedrich LLP
May
21
2014
An Overview of Biosimilars and the Biosimilar Pathway in India Michael Best & Friedrich LLP
Jun
15
2015
Ariosa Diagnostics, Inc. v. Sequenom, Inc. – Another Diagnostic Patent Meets its End Michael Best & Friedrich LLP
Oct
28
2015
Brazil: Federal District Court in Rio de Janeiro Declares AstraZeneca’s Patent Covering Fosladex Invalid Michael Best & Friedrich LLP
Dec
10
2015
Biologics and Biosimilars Bits and Bytes – December 10, 2015 Michael Best & Friedrich LLP
Dec
15
2020
HRSA Publishes Long-Awaited 340B Program Administrative Dispute Resolution Procedures Dinsmore & Shohl LLP
May
22
2013
EPA Declines to Create New Air Pollution Control Program for Coal Mines – For Now. Dinsmore & Shohl LLP
Apr
12
2019
Possible Changes to the Legalization and Regulation of Hemp and CBD Oil Dinsmore & Shohl LLP
Aug
23
2023
Fifth Circuit Court Keeps Abortion Medication Legal, But with Restrictions Dinsmore & Shohl LLP
Sep
24
2021
HRSA Refers Six Drug Manufacturers to OIG for Possible 340B-Related Civil Penalties Dinsmore & Shohl LLP
Dec
27
2021
CMS Plans to Regulate Pharmacy Benefit Manager DIR Fees Dinsmore & Shohl LLP
Dec
27
2018
Standards for Use of Opiates in Treatment of Pain Changes in Ohio Dinsmore & Shohl LLP
Sep
23
2019
House Vote on Cannabis Industry-Related SAFE Banking Act Scheduled for September 2019 Dinsmore & Shohl LLP
Jul
14
2016
Legalization of Medical Marijuana in Ohio and Impact on Your Workers’ Compensation Program Dinsmore & Shohl LLP
Dec
2
2021
Federal Court Pauses CMS COVID-19 Vaccine Mandate For Health Care Workers; Employers May Still Require Employee Vaccination Dinsmore & Shohl LLP
Jun
24
2019
Recreational Marijuana – Insights for Employers Dinsmore & Shohl LLP
Aug
7
2015
Ohio’s New OARRS Standards and Procedures Dinsmore & Shohl LLP
Sep
21
2010
EPA Looks to the Sky for New Limits on Natural Gas Dinsmore & Shohl LLP
Jul
2
2018
Attorney General Announces Ninth Annual Fraud Takedown Targeting Opioid Epidemic Dinsmore & Shohl LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins